Search

Author/Creator Anderson, Luke

1. Tunable three-dimensional engineered prostate cancer tissues for in vitro recapitulation of heterogeneous in vivo prostate tumor stiffness. (15th July 2022)

Authors:
Habbit, Nicole L.; Anbiah, Benjamin; Anderson, Luke; Suresh, Joshita; Hassani, Iman; Eggert, Matthew; Brannen, Andrew; Davis, Joshua; Tian, Yuan; Prabhakarpandian, Balabhaskar; Panizzi, Peter; Arnold, Robert D.; Lipke, Elizabeth A.
Journal:
Acta biomaterialia
Issue:
Volume 147(2022)
Page Start:
73
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy and safety of nilotinib 300 mg twice daily in patients with chronic myeloid leukemia in chronic phase who are intolerant to prior tyrosine kinase inhibitors: Results from the Phase IIIb ENESTswift study. (April 2018)

Authors:
Hiwase, Devendra; Tan, Peter; D'Rozario, James; Taper, John; Powell, Anthony; Irving, Ian; Wright, Matthew; Branford, Susan; Yeung, David T.; Anderson, Luke; Gervasio, Othon; Levetan, Carly; Roberts, Will; Solterbeck, Ann; Traficante, Robert; Hughes, Timothy
Journal:
Leukemia research
Issue:
Volume 67(2018)
Page Start:
109
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗